Skull metastasis revealing a papillary thyroid carcinoma

Although thyroid carcinoma is a relatively common form of malignancy,metastatic spread to the skull is rare.Here,we report a case of papillary thyroid carcinoma with frontal and parietal metastasis.A 61-year-old Chinese woman presented with a one year history of a growing mass on the center of the frontal and parietal bone,initially thought to be meningioma.Biopsy of the skull base mass after intracalvarium excision,indicated a tumor of thyroid origin.One month later the patient underwent a total thyroidectomy.Pathological examination confirmed a diagnosis of papillary thyroid carcinoma with frontal and parietal bone metastasis.Based on this experience,the key to successful management of the skull metastasis of thyroid carcinoma is prompt diagnosis and appropriate treatment.Skull metastasis should be considered at the outset of the clinical course of papillary thyroid cancer.To facilitate this,patients should be meticulously investigated by a multidisciplinary team to improve quality of life.

Malignant pheochromocytoma with cerebral and skull metastasis: A case report and literature review

BACKGROUND Malignant pheochromocytoma with cerebral and skull metastasis is a very rare disease.Combining our case with 16 previously reported cases identified from a PubMed search,an analysis of 17 cases of malignant cerebral pheochromocytoma was conducted.This literature review aimed to provide information on clinical manifestations,radiographic and histopathological features,and treatment strategies of this condition.CASE SUMMARY A 60-year-old man was admitted with a progressive headache and enlarging scalp mass lasting for 3 mo.Radiographic images revealed a left temporal biconvexshaped epidural mass and multiple lytic lesions.The patient underwent a left temporal craniotomy for resection of the temporal tumor.Histopathological analysis led to identification of the mass as malignant pheochromocytoma.The patient’s symptoms were alleviated at the postoperative 3-mo clinical follow-up.However,metastatic pheochromocytoma lesions were found on the right 6th rib and the 6th to 9th thoracic vertebrae on a 1-year clinical follow-up computed tomography scan.CONCLUSION Magnetic resonance spectroscopy and histopathological examination are necessary to make an accurate differential diagnosis between malignant cerebral pheochromocytoma and meningioma.Surgery is regarded as the first choice of treatment.

Spontaneous acute epidural hematoma secondary to skull and dural metastasis of hepatocellular carcinoma: A case report

BACKGROUND The skull and dura are uncommon sites for the metastasis of hepatocellular carcinoma(HCC).Spontaneous acute epidural hematoma(AEDH)is also very rare.We report here a spontaneous AEDH secondary to skull and dural metastasis of HCC.This case is extremely rare.CASE SUMMARY A 48-year-old male patient with a history of HCC developed unconsciousness spontaneously.Head computed tomography showed"a huge AEDH in the left parietal and occipital region with osteolytic destruction of the left parietal bone.Emergent operation was performed to evacuate the hematoma and resect the lesion.Pathological study revealed that the lesion was the metastases from HCC.The patient died of lung infection,anemia,and liver failure 3 wk after operation.CONCLUSION Spontaneous AEDH caused by hepatocellular carcinoma(HCC)dural and skull metastases is extremely rare,the outcome is poor.So,early diagnosis is important.If the level of AFP does not decrease with the shrinkage of intrahepatic lesions after treatment,it is necessary to be alert to the existence of extrahepatic metastases.Since most of the patients had scalp and bone masses,physicians should pay attention to the patient's head palpation.Once a patient with the history of HCC had sudden neurological dysfunction,the possibility of spontaneous AEDH caused by the skull and dura mater metastases should be considered.Since hemorrhage is common in the skull HCC metastases,for patients with spontaneous AEDH accompanied by skull osteolytic lesions,it is also necessary to be alert to the possibility of HCC.For AEDH secondary to HCC metastases,early diagnosis and timely treatment are critical to improve the patients’outcomes.

Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma

The incidence of bone metastases(BMs)from hepatocellular carcinoma(HCC)is relatively low compared to those of other cancers,but it has increased recently,especially in Asian countries.Typically,BMs from HCC appear radiologically as osteolytic,destructive,and expansive components with large,bulky soft-tissue masses.These soft-tissue masses are unique to bone metastases from HCC and often replace the normal bone matrix and exhibit expansive growth.They often compress the peripheral nerves,spinal cord,or cranial nerves,causing not only bone pain but also neuropathic pain and neurological symptoms.In patients with spinal BMs,the consequent metastatic spinal cord compression(MSCC)causes paralysis.Skull base metastases(SBMs)with cranial nerve involvement can cause neurological symptoms.Therefore,patients with bony lesions often suffer from pain or neurological symptoms that have a severe,adverse effect on the quality of life.External-beam radiotherapy(EBRT)can effectively relieve bone pain and neurological symptoms caused by BMs.However,EBRT is not yet widely used for the palliative management of BMs from HCC because of the limited number of relevant studies.Furthermore,the optimal dosing schedule remains unclear,despite clinical evidence to support single-fraction ra-diation schedules for primary cancers.In this review,we outline data describing palliative EBRT for BMs from HCC in the context of(1)bone pain;(2)MSCC;and(3)SBMs.